Provenance du réseau au premier degré de Aaron Vernon
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Aaron Vernon via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| BLUEBIRD BIO, INC. | Biotechnology | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman | |
| Bentley University | College/University | Undergraduate Degree | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member | |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
| CHIMERIC THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Shawn Tomasello Consulting LLC
 Shawn Tomasello Consulting LLC Miscellaneous Commercial ServicesCommercial Services Shawn Tomasello Consulting LLC provides business consulting services. The private company is based in Miramar Beach. The American company was founded by Shawn Cline Tomasello. | Miscellaneous Commercial Services | Chief Executive Officer | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| DIPLOMAT PHARMACY, INC. | Drugstore Chains | Director/Board Member | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
| The University of Queensland | College/University | Doctorate Degree | |
| New Mexico State University | College/University | Graduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| TRILLIUM THERAPEUTICS | Biotechnology | Investor Relations Contact | |
Shawnigan Lake School
 Shawnigan Lake School Other Consumer ServicesConsumer Services Shawnigan Lake School operates as a not for profit organization. Its programs include arts, athletics, external and summer and global exchange programs. The company was founded by Christopher Windley Lonsdale in 1916 and is headquartered in Shawnigan Lake, Canada. | Other Consumer Services | Director/Board Member | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| EMD Serono Research & Development Institute, Inc. | Corporate Officer/Principal | ||
| University of Regensburg | College/University | Doctorate Degree | |
Molkerei Hainichen Freiberg GmbH & Co. KG
 Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Part of Ehrmann AG, Molkerei Hainichen Freiberg GmbH & Co. KG is a dairy company based in Freiberg, Germany. The CEOs are Christian Ehrmann, Sabine Arazi, Robert Hofmeister. The German company manufactures and produces high-quality dairy products with a focus on sustainability. The company has a code of conduct and offer various career opportunities. The company was founded in 1992. | Food: Meat/Fish/Dairy | Chief Executive Officer | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
| University of Mumbai | College/University | Undergraduate Degree | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Allegheny College | College/University | Undergraduate Degree | |
| Murray State University (Kentucky) | College/University | Masters Business Admin | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carson Group, Inc. (New York)
 Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 39 |
| Australie | 4 |
| Canada | 4 |
| Royaume-Uni | 3 |
| Allemagne | 3 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 13 |
| Finance | 3 |
| Health Services | 3 |
| Commercial Services | 3 |
Opérationnelle
| Corporate Officer/Principal | 32 |
| Director/Board Member | 30 |
| Independent Dir/Board Member | 16 |
| Chief Tech/Sci/R&D Officer | 11 |
| Undergraduate Degree | 9 |
Relations les plus connectées
| Insiders | |
|---|---|
| Shawn Tomasello | 22 |
| Patrick Baeuerle | 19 |
| Garry Menzel | 19 |
| Mayur Ian Somaiya | 11 |
| Priti Hegde | 8 |
| Eric Sullivan | 7 |
| Peter Olagunju | 7 |
| Robert Hofmeister | 5 |
| Rosemary Harrison | 5 |
| Praveen Malhotra | 4 |
| Suzanne Boyd | 3 |
- Bourse
- Insiders
- Aaron Vernon
- Connexions Sociétés
